Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants
PYS Lam, CG Clark, R Li, DJP Pinto… - Journal of medicinal …, 2003 - ACS Publications
As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based
drug design techniques and molecular recognition principles, a systematic study has been …
drug design techniques and molecular recognition principles, a systematic study has been …
[引用][C] Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants
PYS Lam, CG Clark, R Li, DJP Pinto, MJ Orwat… - Journal of Medicinal …, 2003 - infona.pl
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally
Bioavailable Factor Xa Inhibitors as Novel Anticoagulants × Close The Infona portal uses …
Bioavailable Factor Xa Inhibitors as Novel Anticoagulants × Close The Infona portal uses …
[引用][C] Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants
P LAM, CG CLARK, KA ROSSI… - Journal of medicinal …, 2003 - pascal-francis.inist.fr
Author LAM, Patrick Y. S 1; CLARK, Charles G 1; ROSSI, Karen A 1; WRIGHT, Matthew R 1;
BAI, Stephen A 1; HE, Kan 1; LUETTGEN, Joseph M 1; WONG, Pancras C 1; KNABB, Robert …
BAI, Stephen A 1; HE, Kan 1; LUETTGEN, Joseph M 1; WONG, Pancras C 1; KNABB, Robert …
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants.
PY Lam, CG Clark, R Li, DJ Pinto, MJ Orwat… - Journal of Medicinal …, 2003 - europepmc.org
As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based
drug design techniques and molecular recognition principles, a systematic study has been …
drug design techniques and molecular recognition principles, a systematic study has been …
[PDF][PDF] Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants
PYS Lam, CG Clark, R Li, DJP Pinto, MJ Orwat… - J. Med. Chem, 2003 - academia.edu
As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based
drug design techniques and molecular recognition principles, a systematic study has been …
drug design techniques and molecular recognition principles, a systematic study has been …
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants
PYS Lam, CG Clark, R Li, DJP Pinto… - Journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based
drug design techniques and molecular recognition principles, a systematic study has been …
drug design techniques and molecular recognition principles, a systematic study has been …
[引用][C] Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants
PYS Lam, CG Clark, R Li, DJP Pinto, MJ Orwat… - Journal of Medicinal …, 2003 - cir.nii.ac.jp
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable
Factor Xa Inhibitors as Novel Anticoagulants | CiNii Research CiNii 国立情報学研究所 学術 …
Factor Xa Inhibitors as Novel Anticoagulants | CiNii Research CiNii 国立情報学研究所 学術 …